Edition:
United States

Biohit Oyj (BIOBV.HE)

BIOBV.HE on Helsinki Stock Exchange

5.26EUR
22 Sep 2017
Change (% chg)

€-0.04 (-0.75%)
Prev Close
€5.30
Open
€5.30
Day's High
€5.30
Day's Low
€5.22
Volume
4,560
Avg. Vol
12,467
52-wk High
€6.85
52-wk Low
€5.11

Latest Key Developments (Source: Significant Developments)

Biohit H1 operating result swings to profit of EUR 7.4 mln
Thursday, 17 Aug 2017 02:30am EDT 

Aug 17 (Reuters) - BIOHIT OYJ :H1 NET SALES EUR ‍4.1​ MILLION VERSUS EUR 3.8 MILLION YEAR AGO.‍NET SALES GROWTH IS EXPECTED IN 2017.​.NET SALES GROWTH IS EXPECTED IN 2017..COMPANY DOES NOT ASSESS WHEN RESULT ADJUSTED FOR ITEMS AFFECTING COMPARABILITY WILL TURN POSITIVE.H1 OPERATING PROFIT EUR 7.4 MILLION INCLUDING PROFIT OF EUR 8.4 MILLION BOOKED FROM JOINT VENTURE EXIT (EUR -2.1 MILLION).  Full Article

Chinmax Medical Systems to distribute Acetium Lozenge in China
Monday, 5 Jun 2017 02:30am EDT 

June 5 (Reuters) - BIOHIT OYJ : :CHINMAX MEDICAL SYSTEMS INC. TO DISTRIBUTE ACETIUM® LOZENGE IN CHINA .‍BIOHIT OYJ AND CHINMAX MEDICAL SYSTEMS INC. HAVE SIGNED AN AGREEMENT FOR DISTRIBUTION OF ACETIUM LOZENGE IN CHINA.​.‍AGREEMENT HAS BEEN SIGNED FOR A PRELIMINARY PERIOD OF SEVEN YEARS​.  Full Article

Biohit H2 operating loss flat at EUR 1.3 mln
Monday, 20 Feb 2017 02:30am EST 

Biohit Oyj : H2 net sales 4.4 million euros ($4.67 million) versus 2.5 million euros year ago . H2 operating loss 1.3 million euros versus loss 1.4 million euros year ago . Board of directors proposes to annual general meeting that no dividend be paid for financial year . China's operations are in Biohit's focus in 2017 . Expects to complete reduction of joint venture share capital during Q1 of 2017 . Estimates its non-comparable operating result to turn clearly positive for 2017 . Net sales growth is expected in 2017 .Company does not assess when comparable result will turn to positive.  Full Article

Biohit and R-kioski to start cooperation
Wednesday, 16 Nov 2016 02:30am EST 

Biohit Oyj : Biohit Oyj and R-kioski to start cooperation . R-Kioski will sell and promote gift cards for Biohit's health checks for its consumers in R-kioski convenience stores across Finland .Agreement will enter into force immediately and will start with launch during December 2016.  Full Article

Glomedics to distribute Biohit lactose intolerance test in South Korea
Friday, 2 Sep 2016 08:00am EDT 

Biohit Oyj :Says has signed agreement with Glomedics for distribution of Biohit Lactose Intolerance Quick Test in South Korea.  Full Article

Biohit signs distribution deal for GA-map dysbiosis test in China
Monday, 22 Aug 2016 02:30am EDT 

Biohit Oyj :Beijing Huayihuilang Medical Instrument Co., Ltd. to distribute GA-map dysbiosis test in China.  Full Article

Biohit H1 operating loss widening to SEK 2.1 million
Thursday, 18 Aug 2016 02:30am EDT 

Biohit Oyj : H1 net sales 3.8 million euros versus 3.5 million euros year ago . H1 operating loss 2.1 million euros versus loss 1.5 million euros year ago . Net sales growth is expected in 2016 .Says does not publish forecasts when result will turn to positive.  Full Article

Biohit: Population-based screening study for gastric cancer risk is completed
Monday, 1 Aug 2016 06:45am EDT 

Biohit Oyj : A population-based screening study for gastric cancer risk has been completed in Russia .The study results confirm the previous study results showing that GastroPanel detects patients at increased risk for developing gastric cancer.  Full Article

Biohit and Pyynikin Craft Brewery to start cooperation
Wednesday, 6 Jul 2016 02:30am EDT 

Biohit Oyj : Biohit Oyj and Pyynikin Craft Brewery to start cooperation .Pyynikin Craft Brewery will launch a new beer brand called Pyynikin Vapaa (Pyynikki's Free) during the summer.  Full Article

Biohit signs distribution agreement with Pooyandegan Pezeshki Pardis
Wednesday, 18 May 2016 02:30am EDT 

Biohit Oyj :Biohit Oyj and Pooyandegan Pezeshki Pardis have signed an agreement for the distribution of the Biohit Unified GastroPanel test in Iran.  Full Article

BRIEF-Patent granted to Biohit Acetium® capsule in Japan

* AN IMPORTANT PATENT GRANTED TO BIOHIT ACETIUM® CAPSULE IN JAPAN

No consensus analysis data available.